Full List Of Stories
US close: Stocks mixed as more Q2 earnings roll in
Wall Street stocks turned in a mixed performance on Thursday after snapping a two-day losing streak in the previous session.
Broker tips: Sage, Ergomed, Travis Perkins, Smith & Nephew
Analysts at Canaccord Genuity upgraded software firm Sage from 'hold' to 'buy' on Thursday, stating the group was "more resilient than you think".
US open: Stocks in the red as earnings continue to stream in
Wall Street stocks were in the red early on Thursday after major indices snapped a two-day losing streak in the previous session.
US initial claims come in higher than expected
Americans filed first-time jobless claims at an accelerated week-on-week clip in the seven days ended 30 July.
Canaccord Genuity upgrades Sage to 'buy'
Analysts at Canaccord Genuity upgraded software firm Sage from 'hold' to 'buy' on Thursday, stating the group was "more resilient than you think".
US pre-open: Futures trade higher after major indices snap two-day losing streak
Wall Street futures had stocks opening higher ahead of the bell on Thursday after major indices snapped a two-day losing streak in the previous session.
Berenberg initiates coverage on Ergomed at 'buy'
Analysts at Berenberg initiated coverage on biopharmaceutical industry services provider Ergomed at 'buy' on Thursday, stating the group was "perfectly positioned".
SCS Group profits seen ahead of FY expectations
Furniture and floorings retailer SCS Group said on Thursday that full-year profits had come in ahead of market expectations thanks to positive trading, strong margins, and effective cost management.
Evraz H1 net profits tumble 99.5%
Russia-focussed steel producer Evraz said on Thursday that net profits had fallen to next to nothing in the six months ended 30 June.
AstraZeneca breast cancer drug receives EU approval
Drugmaker AstraZeneca's Lynparza has received European Union approval for use in the adjuvant treatment of adult patients with high-risk early-stage breast cancer, including those with germline BRCA mutations.
Informa FY revenue and profits seen at 'top-end' of guidance
Publishing and exhibitions group Informa reiterated full-year guidance on Thursday after witnessing "strong" revenue and adjusted profit growth throughout the six months ended 30 June.
Glencore posts massive $10.3bn rise in interim core profits, Next experiences 'sharp reversal' of Covid lockdown trends
London pre-open The FTSE 100 was being called to open just 5. 2 points firmer ahead of the bell on Thursday after closing 0. 49% higher in the previous session at 7,445. 68.
Next experiences 'sharp reversal' of lockdown trends in H1
Clothing retailer Next said on Thursday that sales in the first half had been "dominated" by "a sharp reversal" of the previous year's lockdown trends.